263 related articles for article (PubMed ID: 18633446)
1. Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.
Pechan P; Rubin H; Lukason M; Ardinger J; DuFresne E; Hauswirth WW; Wadsworth SC; Scaria A
Gene Ther; 2009 Jan; 16(1):10-6. PubMed ID: 18633446
[TBL] [Abstract][Full Text] [Related]
2. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys.
Lai CM; Shen WY; Brankov M; Lai YK; Barnett NL; Lee SY; Yeo IY; Mathur R; Ho JE; Pineda P; Barathi A; Ang CL; Constable IJ; Rakoczy EP
Mol Ther; 2005 Oct; 12(4):659-68. PubMed ID: 16023893
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model.
Igarashi T; Miyake K; Kato K; Watanabe A; Ishizaki M; Ohara K; Shimada T
Gene Ther; 2003 Feb; 10(3):219-26. PubMed ID: 12571629
[TBL] [Abstract][Full Text] [Related]
4. Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration.
Honda M; Sakamoto T; Ishibashi T; Inomata H; Ueno H
Gene Ther; 2000 Jun; 7(11):978-85. PubMed ID: 10849558
[TBL] [Abstract][Full Text] [Related]
5. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
[TBL] [Abstract][Full Text] [Related]
6. Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8.
Natkunarajah M; Trittibach P; McIntosh J; Duran Y; Barker SE; Smith AJ; Nathwani AC; Ali RR
Gene Ther; 2008 Mar; 15(6):463-7. PubMed ID: 18004402
[TBL] [Abstract][Full Text] [Related]
7. Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.
Askou AL; Pournaras JA; Pihlmann M; Svalgaard JD; Arsenijevic Y; Kostic C; Bek T; Dagnaes-Hansen F; Mikkelsen JG; Jensen TG; Corydon TJ
J Gene Med; 2012 Nov; 14(11):632-41. PubMed ID: 23080553
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.
Bainbridge JW; Mistry A; De Alwis M; Paleolog E; Baker A; Thrasher AJ; Ali RR
Gene Ther; 2002 Mar; 9(5):320-6. PubMed ID: 11938451
[TBL] [Abstract][Full Text] [Related]
9. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer.
Rota R; Riccioni T; Zaccarini M; Lamartina S; Gallo AD; Fusco A; Kovesdi I; Balestrazzi E; Abeni DC; Ali RR; Capogrossi MC
J Gene Med; 2004 Sep; 6(9):992-1002. PubMed ID: 15352072
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
Zhang M; Yang Y; Yan M; Zhang J
Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
[TBL] [Abstract][Full Text] [Related]
13. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for ocular angiogenesis.
Bainbridge JW; Mistry AR; Thrasher AJ; Ali RR
Clin Sci (Lond); 2003 Jun; 104(6):561-75. PubMed ID: 12570869
[TBL] [Abstract][Full Text] [Related]
15. A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization.
Li Y; Zhu P; Verma A; Prasad T; Deng H; Yu D; Li Q
J Cell Mol Med; 2017 Aug; 21(8):1555-1571. PubMed ID: 28332318
[TBL] [Abstract][Full Text] [Related]
16. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy.
Lai YK; Shen WY; Brankov M; Lai CM; Constable IJ; Rakoczy PE
Gene Ther; 2002 Jun; 9(12):804-13. PubMed ID: 12040462
[TBL] [Abstract][Full Text] [Related]
17. In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy.
Le Gat L; Gogat K; Bouquet C; Saint-Geniez M; Darland D; Van Den Berghe L; Marchant D; Provost A; Perricaudet M; Menasche M; Abitbol M
Gene Ther; 2003 Dec; 10(25):2098-103. PubMed ID: 14595383
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated sFlt-1 gene fragment transfer suppresses retinal neovascularization.
Min Z; Qiang W; Benwen S; Bin L; Xinhua D
Curr Eye Res; 2009 May; 34(5):401-10. PubMed ID: 19401884
[TBL] [Abstract][Full Text] [Related]
19. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of leukemia inhibitory factor (LIF) blocks normal vascular development but not pathological neovascularization in the eye.
Ash J; McLeod DS; Lutty GA
Mol Vis; 2005 Apr; 11():298-308. PubMed ID: 15889014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
